RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

NCT00935961 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

HEAD & NECK Cancer

Interventions

DRUG: RAD001 + docetaxel + cisplatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]